Hsiao C.-C.MING YAOJIA-HAU LIUWEI-LI CHEN2020-10-222020-10-2220181442-6404https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041605266&doi=10.1111%2fceo.13139&partnerID=40&md5=b354bb76bbd637ce4e89e0849f3ba1dchttps://scholars.lib.ntu.edu.tw/handle/123456789/517787[SDGs]SDG3artificial tear; pembrolizumab; steroid; immunological antineoplastic agent; monoclonal antibody; pembrolizumab; acute corneal toxicity; acute myeloid leukemia; adult; allogeneic stem cell transplantation; case report; clinical article; cornea disease; eye surgery; female; graft versus host reaction; graft versus leukemia effect; human; Letter; male; single drug dose; tarsorrhaphy; young adult; acute disease; acute myeloid leukemia; chemically induced; confocal microscopy; cornea; cornea disease; cornea epithelium; drug effect; hematopoietic stem cell transplantation; pathology; slit lamp microscopy; Acute Disease; Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Cornea; Corneal Diseases; Epithelium, Corneal; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Microscopy, Confocal; Slit Lamp Microscopy; Young AdultPembrolizumab induced acute corneal toxicity after allogeneic stem cell transplantationletter10.1111/ceo.13139292805372-s2.0-85041605266